Author name: DrugPatentWatch

A robust drug patent portfolio is not just an asset—it’s a critical tool for success. As companies invest billions in […]

Protecting your intellectual property is paramount. Drug patent prosecution is a complex and critical process that can make or break

Flexibility has become more than just a buzzword – it’s a necessity. Contract Development and Manufacturing Organizations (CDMOs) are at

When it comes to researching and navigating the complex world of drug patents, inventors and researchers often turn to various

The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to outsource various stages of drug development and

Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand

The generic drug market in the United States faces significant challenges, including price volatility, supply chain disruptions, and strategies employed

The biopharmaceutical industry has witnessed a significant surge in the number of therapeutic molecules in development, leading to a corresponding

Achieving operational excellence in a Contract Development and Manufacturing Organization (CDMO) is crucial to ensure the quality and consistency of